
NASDAQFinancial ServicesAsset Management
Latest quote
$4.77
+$0.02 · +0.42%
ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies. The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.
Latest quote
$4.77
+$0.02 · +0.42%
After-hours
$4.7506
−$0.0194 · -0.41%
Oct 7, 7:30 PM ET
Regular session · ET · Market data may be delayed.
ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies. The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.
Day range
Current $4.77
52-week range
Current $4.77
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
31
Expensive
Sentiment
43
Mixed
Risk
82
Extreme Risk
Momentum
23
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies. The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.
Day range
Current $4.77
52-week range
Current $4.77
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 35.68M USD | 59.51M USD | 76.07M USD | 33.4M USD | 8.98M USD |
| Cost of goods sold | 40.5M USD | 47.01M USD | 58.33M USD | 20.15M USD | 6.56M USD |
| Gross profit | −4.82M USD | 12.5M USD | 17.74M USD | 13.25M USD | 2.43M USD |
| Research and development | 238K USD | 418K USD | 62K USD | 388K USD | 132K USD |
| Selling, general, and administrative | 1.21M USD | 23.08M USD | 23.34M USD | 28.78M USD | 17.76M USD |
| Operating expenses | 4.74M USD | 28.14M USD | 68.09M USD | 60.47M USD | 21.43M USD |
| Interest income | — | — | — | 29K USD | — |
| Interest expense | 199K USD | 213K USD | 92K USD | — | 32K USD |
| Depreciation and amortization | 582K USD | 768K USD | 2.34M USD | 2.63M USD | 501K USD |
| Operating income | −9.56M USD | −15.65M USD | −50.35M USD | −47.22M USD | −19M USD |
| Net income | −120.85M USD | −15.91M USD | −57.04M USD | −52.42M USD | −21.25M USD |
Company facts updated Oct 8, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Aug 4, 2025 | 1:39 | — | — |
Stock split | Jun 9, 2023 | 1:20 | — | — |
Effective Aug 4, 2025
1:39
Effective Jun 9, 2023
1:20
Funds reporting this stock among their holdings, ordered by reported position size.
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.